Morgan Stanley’s Kiora Pharmaceuticals KPRX Stock Holding History

Morgan Stanley’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.72K	Buy	+1,408	New	+$2.97K	﹤0.01%	7272
2025 Q2	–	Sell	-700	Closed	-$2.11K	–	8199
2025 Q1	$2.11K	Buy	+700	New	+$2.43K	﹤0.01%	7168
2024 Q3	–	Sell	-1	Closed	-$4	–	7989
2024 Q2	$4	Hold	1	–	–	﹤0.01%	7812
2024 Q1	$6	Sell	1 -1	-50%	-$6	﹤0.01%	7786
2023 Q4	$8	Buy	2 +1	+100%	+$5	﹤0.01%	7787
2023 Q3	$5	Hold	1	–	–	﹤0.01%	7576
2023 Q2	$5	Hold	1	–	–	﹤0.01%	7623
2023 Q1	$27	Sell	1 -12	-92%	-$448	﹤0.01%	7628
2022 Q4	$397	Sell	13 -251	-95%	-$11.6K	﹤0.01%	7582
2022 Q3	$15K	Buy	264 +263	+26,300%	+$20.5K	﹤0.01%	6922
2022 Q2	$0	Hold	1	–	–	﹤0.01%	7894
2022 Q1	$0	Hold	1	–	–	﹤0.01%	8041
2021 Q4	$1K	Hold	1	–	–	﹤0.01%	7874
2021 Q3	$1K	Hold	1	–	–	﹤0.01%	7784
2021 Q2	$2K	Hold	1	–	–	﹤0.01%	7528
2021 Q1	$2K	Hold	1	–	–	﹤0.01%	7271
2020 Q4	$2K	Hold	1	–	–	﹤0.01%	6894
2020 Q3	$2K	Hold	1	–	–	﹤0.01%	6573
2020 Q2	$2K	Hold	1	–	–	﹤0.01%	6450
2020 Q1	$2K	Hold	1	–	–	﹤0.01%	6389
2019 Q4	$3K	Hold	1	–	–	﹤0.01%	6461
2019 Q3	$1K	Hold	1	–	–	﹤0.01%	6553
2019 Q2	$1K	Hold	1	–	–	﹤0.01%	6546
2019 Q1	$2K	Hold	1	–	–	﹤0.01%	6455
2018 Q4	$2K	Hold	1	–	–	﹤0.01%	6419
2018 Q3	$2K	Hold	1	–	–	﹤0.01%	6575
2018 Q2	$3K	Hold	1	–	–	﹤0.01%	6508
2018 Q1	$3K	Buy	+1	New	+$4.32K	﹤0.01%	6457
2017 Q4	–	Hold	0	–	–	–	6488
2017 Q3	–	Hold	0	–	–	–	6448
2017 Q2	–	Hold	0	–	–	–	6506
2017 Q1	–	Hold	0	–	–	–	6423
2016 Q4	–	Hold	0	–	–	–	6440
2016 Q3	–	Hold	0	–	–	–	6426
2016 Q2	–	Sell	-1	Closed	-$17.4K	–	6301
2016 Q1	$16K	Hold	1	–	–	﹤0.01%	5998
2015 Q4	$14K	Buy	+1	New	+$16.1K	﹤0.01%	6142
2015 Q3	–	Hold	0	–	–	–	6448

Other funds holding KPRX

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley's KPRX Position: Q1 2026 in Review

Morgan Stanley opened a new position in Kiora Pharmaceuticals (KPRX) in Q1 2026: 1,408 shares worth $2.72K. The stake represents ﹤0.01% of the portfolio and ranks #7272 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in KPRX as recently as Q1 2025.

Morgan Stanley first reported a position in KPRX in Q4 2015 and has held it in 30 quarters since. The position peaked at $16K in Q1 2016. 18 funds tracked by Wall St. Rank hold KPRX as of Q1 2026.

Morgan Stanley held 1,408 shares of Kiora Pharmaceuticals worth $2.72K as of Q1 2026.
Kiora Pharmaceuticals was a new Morgan Stanley position in Q1 2026.
Kiora Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7272 holding.
Morgan Stanley first reported a position in Kiora Pharmaceuticals in Q4 2015 and has held it in 30 quarters since.
Morgan Stanley's Kiora Pharmaceuticals position peaked at $16K in Q1 2016.
18 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.